GA831005: Fmoc-Thr((Ac)3-Rha-β-D)-OH Pack Size:50 mg N-α-Fmoc-O-β-(tetra-O-acetyl-α-D-glucopyranosyl-(1

N-α-Fmoc-O-β-(tetra-O-acetyl-α-D-glucopyranosyl-(1

2-Azidoethyl 2-(Acetylamino)-2-deoxy-α-D-galactopyranoside

Nα-(Fluoren-9-ylmethoxycarbonyl)-O-[(methyl 5-acetamido-3

32 / An α-D-N-acetylgalactosamine (GalNAcα) ligand equipped with a terminal carboxylic acid through a short butyl spacer

3-triazole linkages

GA831005: Fmoc-Thr((Ac)3-Rha-β-D)-OH Pack Size:50 mg N-α-Fmoc-O-β-(tetra-O-acetyl-α-D-glucopyranosyl-(1C25H29NO9 487. 5 An Fmoc protected L threonine building block carrying a D rhamnose residue, designed for solid phase peptide synthesis (SPPS) of glycopeptides. The N Fmoc group is removed under standard base conditions (piperidine) during chain elongation, while the free carboxylic acid is available for coupling to the growing resin bound peptide. The sugar hydroxyl groups are protected as three acetate esters (Ac3), which keep the glycan inert